Breast Cancer
Showing NaN - NaN of 167
Breast Cancer Trial in San Francisco (Intake Session, Individual Sessions, Group Sessions)
Not yet recruiting
- Breast Cancer
- Intake Session
- +4 more
-
San Francisco, CaliforniaZuckerberg San Francisco General
Sep 20, 2023
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
Recruiting
- Breast Cancer
- Magnetic Resonance Imaging Simulation
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 5, 2023
Breast Cancer Trial in San Francisco (Tranexamic Acid, Saline)
Recruiting
- Breast Cancer
- Tranexamic Acid
- Saline
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 13, 2023
Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)
Active, not recruiting
- Breast Cancer
- HKI-272
- +3 more
-
San Francisco, California
- +17 more
Jan 30, 2023
Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCEĀ®))
Recruiting
- Breast Cancer
- ARV-471
- ARV-471 in combination with palbociclib (IBRANCEĀ®)
-
Palo Alto, California
- +16 more
Jan 30, 2023
Breast Cancer, Pain Trial in United States (acupuncture therapy, sham acupuncture)
Completed
- Breast Cancer
- Pain
- acupuncture therapy
- sham acupuncture
-
Antioch, California
- +46 more
Dec 5, 2022
Breast Cancer, Non-small Cell Lung Carcinoma Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Pembrolizumab)
Recruiting
- Breast Cancer
- Non-small Cell Lung Carcinoma
- Trastuzumab deruxtecan (DS-8201a)
- Pembrolizumab
-
San Francisco, California
- +24 more
Nov 30, 2022
Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)
Recruiting
- Breast Cancer
- MammaPrint, BluePrint, and Full-Genome Testing
-
Birmingham, Alabama
- +117 more
Dec 1, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)
Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or
Active, not recruiting
- Melanoma
- +8 more
- Pegilodecakin
- +9 more
-
Los Angeles, California
- +9 more
Nov 15, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T
Recruiting
- Breast Cancer
- +8 more
- P-MUC1C-ALLO1 CAR-T cells
- Rimiducid
-
San Francisco, California
- +4 more
Oct 26, 2022
Non Small Cell Lung Cancer, Breast Cancer Trial in Worldwide (Abemaciclib, Pembrolizumab, Anastrozole)
Active, not recruiting
- Non Small Cell Lung Cancer
- Breast Cancer
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +22 more
Aug 8, 2022